These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
623 related articles for article (PubMed ID: 1904004)
21. The role of HLA class I antigens in recognition of melanoma cells by tumor-specific cytotoxic T lymphocytes. Evidence for shared tumor antigens. Darrow TL; Slingluff CL; Seigler HF J Immunol; 1989 May; 142(9):3329-35. PubMed ID: 2785141 [TBL] [Abstract][Full Text] [Related]
22. Characterization of human autotumor-reactive T-cell clones obtained from tumor-infiltrating lymphocytes in liver metastasis of gastric carcinoma. Shimizu Y; Weidmann E; Iwatsuki S; Herberman RB; Whiteside TL Cancer Res; 1991 Nov; 51(22):6153-62. PubMed ID: 1718596 [TBL] [Abstract][Full Text] [Related]
23. Immunoselection of a human melanoma resistant to specific lysis by autologous tumor-infiltrating lymphocytes. Possible mechanisms for immunotherapeutic failures. Topalian SL; Kasid A; Rosenberg SA J Immunol; 1990 Jun; 144(11):4487-95. PubMed ID: 2160503 [TBL] [Abstract][Full Text] [Related]
24. Generation of melanoma-specific, cytotoxic CD4(+) T helper 2 cells: requirement of both HLA-DR15 and Fas antigens on melanomas for their lysis by Th2 cells. Zennadi R; Abdel-Wahab Z; Seigler HF; Darrow TL Cell Immunol; 2001 Jun; 210(2):96-105. PubMed ID: 11520076 [TBL] [Abstract][Full Text] [Related]
25. Generation of human autologous melanoma-specific cytotoxic T-cells using HLA-A2-matched allogeneic melanomas. Crowley NJ; Slingluff CL; Darrow TL; Seigler HF Cancer Res; 1990 Feb; 50(3):492-8. PubMed ID: 2404572 [TBL] [Abstract][Full Text] [Related]
26. Interferon-gamma regulates the T cell response to precursor nevi and biologically early melanoma. Guerry D; Alexander MA; Elder DE; Herlyn MF J Immunol; 1987 Jul; 139(1):305-12. PubMed ID: 3108402 [TBL] [Abstract][Full Text] [Related]
27. Superior antitumor in vitro responses of allogeneic matched sibling compared with autologous patient CD8+ T cells. Kausche S; Wehler T; Schnürer E; Lennerz V; Brenner W; Melchior S; Gröne M; Nonn M; Strand S; Meyer R; Ranieri E; Huber C; Falk CS; Herr W Cancer Res; 2006 Dec; 66(23):11447-54. PubMed ID: 17145892 [TBL] [Abstract][Full Text] [Related]
28. Human tumor-infiltrating CD4+ T cells react to B cell lines expressing heat shock protein 70. Yoshino I; Goedegebuure PS; Peoples GE; Lee KY; Eberlein TJ J Immunol; 1994 Nov; 153(9):4149-58. PubMed ID: 7930618 [TBL] [Abstract][Full Text] [Related]
29. Clonal analysis of lymphocytes from tumor, peripheral blood, and nontumorous kidney in primary renal cell carcinoma. Kim TY; von Eschenbach AC; Filaccio MD; Hayakawa K; Parkinson DR; Balch CM; Itoh K Cancer Res; 1990 Sep; 50(17):5263-8. PubMed ID: 2143685 [TBL] [Abstract][Full Text] [Related]
30. A B7-1-transfected human melanoma line stimulates proliferation and cytotoxicity of autologous and allogeneic lymphocytes. Sulé-Suso J; Arienti F; Melani C; Colombo MP; Parmiani G Eur J Immunol; 1995 Oct; 25(10):2737-42. PubMed ID: 7589065 [TBL] [Abstract][Full Text] [Related]
31. T-cell immune function in tumor, skin, and peripheral blood of advanced stage melanoma patients: implications for immunotherapy. Tjin EP; Konijnenberg D; Krebbers G; Mallo H; Drijfhout JW; Franken KL; van der Horst CM; Bos JD; Nieweg OE; Kroon BB; Haanen JB; Melief CJ; Vyth-Dreese FA; Luiten RM Clin Cancer Res; 2011 Sep; 17(17):5736-47. PubMed ID: 21750202 [TBL] [Abstract][Full Text] [Related]